1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Vaccine Contract Manufacturing Market
2.3. Global Vaccine Contract Manufacturing Market, By Service, 2025 (US$ Million)
2.4. Global Vaccine Contract Manufacturing Market, By Application, 2025 (US$ Million)
2.5. Global Vaccine Contract Manufacturing Market, By Geography, 2025 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2025
3. Vaccine Contract Manufacturing Market: Competitive Analysis
3.1. Market Positioning of Key Vaccine Contract Manufacturing Market Vendors
3.2. Strategies Adopted by Vaccine Contract Manufacturing Market Vendors
4. Vaccine Contract Manufacturing Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Vaccine Contract Manufacturing Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Cell line/strain development
5.3.2. Upstream process development
5.3.3. Downstream process development
5.3.4. Analytical development
5.3.5. Stability testing
5.3.6. Product release
6. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Human use
6.3.2. Veterinary
7. North America Vaccine Contract Manufacturing Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
7.3. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
7.4. Vaccine Contract Manufacturing Market: By Region, 2024-2034, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
7.4.1.1.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
7.4.1.2.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
7.4.1.3.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
8. UK and European Union Vaccine Contract Manufacturing Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
8.3. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
8.4. Vaccine Contract Manufacturing Market: By Region, 2024-2034, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
8.4.1.1.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
8.4.1.2.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
8.4.1.3.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
8.4.1.4.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
8.4.1.5. France
8.4.1.5.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
8.4.1.5.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
8.4.1.6.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
9. Asia Pacific Vaccine Contract Manufacturing Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
9.3. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
9.4. Vaccine Contract Manufacturing Market: By Region, 2024-2034, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
9.4.1.1.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
9.4.1.2.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
9.4.1.3. India
9.4.1.3.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
9.4.1.3.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
9.4.1.4.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
9.4.1.5.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
9.4.1.6.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
10. Latin America Vaccine Contract Manufacturing Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
10.3. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
10.4. Vaccine Contract Manufacturing Market: By Region, 2024-2034, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
10.4.1.1.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
10.4.1.2.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
10.4.1.3.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
11. Middle East and Africa Vaccine Contract Manufacturing Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
11.3. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
11.4. Vaccine Contract Manufacturing Market: By Region, 2024-2034, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
11.4.1.1.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
11.4.1.2.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Vaccine Contract Manufacturing Market: By Service, 2024-2034, USD (Million)
11.4.1.3.2. Vaccine Contract Manufacturing Market: By Application, 2024-2034, USD (Million)
12. Company Profile
12.1. Ajinomoto Althea, Inc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Albany Molecular Research, Inc.
12.3. Cobra Biologics & Pharmaceutical Services
12.4. Cytovance Biologics
12.5. Catalent, Inc.
12.6. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
12.7. ICON plc.
12.8. IDT Biologika GmbH
12.9. Lonza Group, Ltd.
12.10. Merck KGaA
12.11. Paragon Bioservices, Inc.
12.12. PRA Health Sciences
12.13. Others notable players
